Compare RNXT & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNXT | SDHC |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4M | 83.9M |
| IPO Year | 2021 | 2023 |
| Metric | RNXT | SDHC |
|---|---|---|
| Price | $1.16 | $10.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | $7.13 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 360.8K | 37.4K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | $1,123,000.00 | ★ $971,116,000.00 |
| Revenue This Year | $244.84 | $7.91 |
| Revenue Next Year | $195.26 | $9.68 |
| P/E Ratio | ★ N/A | $60.63 |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $9.61 |
| 52 Week High | $2.59 | $23.49 |
| Indicator | RNXT | SDHC |
|---|---|---|
| Relative Strength Index (RSI) | 36.64 | 45.75 |
| Support Level | $1.09 | $9.82 |
| Resistance Level | $1.30 | $10.76 |
| Average True Range (ATR) | 0.12 | 0.43 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 36.72 | 34.63 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Smith Douglas Homes Corpis a builder of single-family homes in communities in certain markets in the southeastern and southern United States. The Company's homes and communities are targeted to first-time and empty-nest homebuyers. The Company currently operates in metropolitan Atlanta, Birmingham, Chattanooga, Central Georgia, Charlotte, Dallas-Fort Worth, Greenville, Alabama Gulf Coast, Huntsville, Nashville, Raleigh and Houston. Its operations are currently organized into ten geographical divisions which comprise two reportable segments. Its Southeast segment consists of its Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of its Alabama, Dallas-Fort Worth, Houston, Nashville, and Alabama Gulf Coast divisions.